NCT04802876 2025-03-21ACROPOLISOLTI Breast Cancer Research GroupPhase 2 Active not recruiting184 enrolled
NCT04866836 2025-03-21A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant TumorsThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Terminated20 enrolled
NCT03779100 2019-01-28Lenvatinib Plus PD-1 Antibody for Unresectable ICCSun Yat-sen UniversityPhase 2 Suspended25 enrolled